Shanghai Kehua Bio-Engineering Co.,Ltd
Status: Publicly traded
Direct answer
Shanghai Kehua Bio-Engineering Co.,Ltd is publicly traded on SHZ under the ticker 002022.SZ.
Shanghai Kehua Bio-Engineering Co.,Ltd (SKBE), founded in 1981 and headquartered in Shanghai, China, is a leading enterprise specializing in the research, development, manufacturing, and sale of in vitro diagnostic (IVD) products. While primarily serving the Chinese market, the company also has a significant international presence, exporting its Kehua-branded products to 38 countries and regions worldwide. SKBE's...
Can you invest in Shanghai Kehua Bio-Engineering Co.,Ltd?
Yes. Shanghai Kehua Bio-Engineering Co.,Ltd is publicly traded on SHZ under the ticker 002022.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Shanghai Kehua Bio-Engineering Co.,Ltd
Detailed equity research is provided by MarketSnap.